Lerner Neil bought 2,500 shares of Compass Therapeutics, Inc. at $1.14 for $2.85k on Sep 24, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Accounting Officer
Chief Accounting Officer
Filed Sep 25, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$2,850Shares × reported price
Shares traded
2,500Common Stock
Price per share
$1.14Reported price. Read footnotes for ranges.
% of reported position traded
0.63%This security and ownership context
Holdings after
400,000Direct
Trade date
Sep 24, 2026Buy
Filed
Sep 25, 2026, 8:01 AM ET1-day reporting delay
Accession
0001171843-26-006235Code P · Transaction 229547
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 397,500 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CMPX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CMPX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +124%1w ago +124%1d ago +124%
Returns since7d −24%30d −32%90d180d1y

Footnotes in full

F1: 62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.